ADR-AC GmbH
ADR-AC GmbH specializes in the diagnosis, consulting, and research of drug hypersensitivity and allergies through advanced laboratory and clinical services.
About
ADR-AC GmbH is a Switzerland-based company specializing in the diagnosis and treatment of sensitivities, allergies, and adverse drug reactions. Combining extensive clinical knowledge (>60 years) and laboratory research (>400 publications), ADR-AC offers reliable testing and consultation services for allergology and immunology, focusing on drug hypersensitivity, chronic urticaria, and personalized precision medicine. Since May 2019, ADR-AC is part of Analiza, continuing operations and expanding its service range across both clinical research and applied lab analysis for the pharmaceutical and healthcare sectors.
Products & Services
- Sensitization and allergy testing
- Adverse drug reaction and drug hypersensitivity analysis
- Diagnostics for chronic urticaria
- In vitro diagnostic assays (e.g., Cyto-LTT, BAT)
- SARS-CoV-2 T cell immunity testing
- Consulting services for allergic and hypersensitivity reactions
- Allergy resource center (scientific news/resources)
- Educational seminars, symposiums, and workshops
Use Cases & Case Studies
- Diagnosis of multiple drug hypersensitivity (MDH) in DRESS patients
- SARS-CoV-2 T cell testing in immunodeficient individuals
- Accelerated drug allergy diagnosis using Cyto-LTT
- Clinical case analysis for drug allergy
Partnerships & Collaborations
- Integrated part of Analiza since 2019
- Collaborations with the Ticinese Allergy and Immunology Association (STAI)
- Partnerships with Quallergy Club for educational events
Awards & Recognition
-
Contact Information
Certifications & Compliance
- 2 SSAI & 2 SSMIG continuing education credits for seminar participation